Open-access upper gastrointestinal endoscopy a decade after the introduction of proton pump inhibitors and Helicobacter pylori eradication: A shift in endoscopic findings

Digestion

Volumn 75, Issue 4, 2007, Pages 227-231

  Van Kerkhoven, Lieke A S ^a,b   Van Rijswijck, Sally J ^a   Van Rossum, Leo G M ^a   Laheij, Robert J F ^a   Witteman, Ellen M ^b   Tan, Adriaan C I T L ^b   Jansen, Jan B M J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

Epidemiology; Eradication; Esophagitis; Gastrointestinal disorders; Gastrointestinal endoscopy; Helicobacter pylori; Peptic ulcer; Proton pump inhibitor

Indexed keywords

PROTON PUMP INHIBITOR;

ADULT; ARTICLE; BARRETT ESOPHAGUS; CONTROLLED STUDY; DUODENITIS; FEMALE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PEPTIC ULCER; PREVALENCE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; STATISTICAL SIGNIFICANCE;

ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; NETHERLANDS; PREVALENCE; PROTON PUMP INHIBITORS; RISK FACTORS; TIME FACTORS;

EID: 36749026675     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000110684     Document Type: Article

References (21)

1. Numans ME, van der GY, de Wit NJ, de Melker RA: How useful is selection based on alarm symptoms in requesting gastroscopy? An evaluation of diagnostic determinants for gastro-oesophageal malignancy. Scand J Gastroenterol 2001;36:437-443.
2. Schaap NP, Houben MH, Driessen WM, van Spreeuwel JP: Endoscopic studies of the digestive tract as a service for family practitioners; experience in the Eindhoven area. Ned Tijdschr Geneeskd 1993;137:1142-1146.
3. Adang RP, Vismans F-JFE, Talmon JL, Hasman A, Ambergen AW, Stockbrügger RW: The diagnostic outcome of upper gastrointestinal endoscopy: are referral source and patient age determining factors? Eur J Gastroenterol Hepatol 1994;6:329-335.
4. Herings RMC, Pannema MJM, Lodder AC, de Graag EJ: PHARMO report: Farmacother Beweg 2000:22-23.
5. Dickman R, Mattek N, Holub J, Peters D, Fass R: Prevalence of upper gastrointestinal tract findings in patients with noncardiac chest pain versus those with gastroesophageal reflux disease (GERD)-related symptoms: results from a National Endoscopic Database. Am J Gastroenterol 2007;102:1173-1179.
6. Hampel H, Abraham NS, El-Serag HB: Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005;143:199-211.
7. El-Serag HB, Graham DY, Satia JA, Rabeneck L: Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol 2005;100:1243-1250.
8. Jacobson BC, Somers SC, Fuchs CS, Kelly CP, Camargo CA Jr: Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med 2006;354:2340-2348.
9. Dent J, El-Serag HB, Wallander MA, Johansson S: Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005;54:710-717.
10. Health Council of the Netherlands. Overweight and Obesity. The Hague, Health Council of the Netherlands, 2003, Publ. No. 2003/07.
11. Haruma K: Review article: influence of Helicobacter pylori on gastro-oesophageal reflux disease in Japan. Aliment Pharmacol Ther 2004;20(suppl 8):40-44.
12. McColl KE: Helicobacter pylori and gastro-oesophageal reflux disease: the European perspective. Aliment Pharmacol Ther 2004;20(suppl 8):36-39.
13. Raghunath AS, Hungin AP, Wooff D, Childs S: Systematic review: the effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis. Aliment Pharmacol Ther 2004;20:733-744.
14. Kupcinskas L, Jonaitis L, Kiudelis G: A 1 year follow-up study of the consequences of Helicobacter pylori eradication in duodenal ulcer patients: unchanged frequency of erosive oesophagitis and decreased prevalence of non-erosive gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 2004;16:369-374.
15. Schwizer W, Thumshirn M, Dent J, Guldenschuh I, Menne D, Cathomas G, Fried M: Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial. Lancet 2001;357:1738-1742.
16. Ott EA, Mazzoleni LE, Edelweiss MI, Sander GB, Wortmann AC, Theil AL, Somm G, Cartell A, Rivero LF, Uchoa DM, Francesconi CF, Prolla JC: Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial. Aliment Pharmacol Ther 2005;21:1231-1239.
17. Loffeld RJ, van der Putten AB: Helicobacter pylori and gastro-oesophageal reflux disease: a cross-sectional epidemiological study. Neth J Med 2004;62:188-191.
18. Holtmann G, Cain C, Malfertheiner P: Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole. Gastroenterology 1999;117:11-16.
19. van Soest EM, Dieleman JP, Siersema PD, Sturkenboom MC, Kuipers EJ: Increasing incidence of Barrett's oesophagus in the general population. Gut 2005;54:1062-1066.
20. Voutilainen M, Mantynen T, Mauranen K, Kunnamo I, Juhola M: Is it possible to reduce endoscopy workload using age, alarm symptoms and H. pylori as predictors of peptic ulcer and oesophagogastric cancers? Dig Liver Dis 2005;37:526-532.
21. Fujiwara Y, Higuchi K, Shiba M, Yamamori K, Watanabe Y, Sasaki E, Tominaga K, Watanabe T, Oshitani N, Arakawa T: Differences in clinical characteristics between patients with endoscopy-negative reflux disease and erosive esophagitis in Japan. Am J Gastroenterol 2005;100:754-758.